Physician profile
Jonathan M Levy
NPI 1245536911
$11,423.05
in general payments reported to CMS, 2019-2025
34 companies · $1,163 in 2025
The $1,163 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,320 · 2020: $435 · 2021: $5,294 · 2022: $781 · 2023: $862 · 2024: $569 · 2025: $1,163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,395 · Travel and Lodging: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,395.04 |
| Travel and Lodging | $198.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,340.79 | 2019-2025 | Prostep Mica, Ortholoc 3di, Gravity |
| Globus Medical, INC. | $1,665.65 | 2019-2025 | Senza |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $578.14 | 2019-2025 | Jublia |
| Abbott Laboratories | $446.67 | 2019-2022 | |
| Bioventus LLC | $438.40 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Amgen INC. | $396.56 | 2024-2025 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $278.37 | 2021-2025 | Nuzyra |
| Smith+Nephew, INC. | $220.22 | 2019-2021 | |
| Musculoskeletal Transplant Foundation INC. | $210.39 | 2021-2023 | |
| Treace Medical Concepts, INC. | $203.74 | 2022-2024 | |
| Organogenesis INC. | $197.30 | 2021-2025 | Puraply Wound Matrix |
| Horizon Therapeutics Plc | $195.17 | 2020-2021 | |
| Advanced Oxygen Therapy INC. | $148.36 | 2019 | |
| Integra Lifesciences Corporation | $116.28 | 2019-2020 | |
| Sebela Pharmaceuticals INC. | $115.34 | 2020-2023 | Naftin, Pramosone |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $100.88 | 2022-2023 | Seglentis |
| Zimmer Biomet Holdings, INC. | $99.35 | 2021 | |
| Grt US Holding, INC. | $99.09 | 2022 | |
| Novastep INC. | $87.46 | 2023 | Peca Bunion Correction System |
| Angiodynamics, INC. | $72.33 | 2023 | Auryon Laser System 100-120 Vac |
| Nevro Corp. | $65.66 | 2021-2022 | |
| Melinta Therapeutics, LLC | $55.82 | 2019-2023 | Orbactiv, Kimyrsa |
| Sandoz INC. | $47.81 | 2019-2021 | |
| Lifenet Health | $42.32 | 2025 | Theragenesis Wound Matrix |
| Gotham Surgical Solutions & Devices, INC. | $29.10 | 2019 | |
| Medtronic, INC. | $28.07 | 2024 | Intellis Adaptivestim |
| Boston Scientific Corporation | $27.18 | 2019 | |
| Resmed Corp | $26.10 | 2023 | |
| Heron Therapeutics, INC. | $16.39 | 2021 | |
| Paragon 28, INC. | $15.75 | 2019 | |
| Convatec INC. | $15.64 | 2021 | |
| Orthofix Medical, INC. | $15.55 | 2022 | |
| Dynasplint Systems INC. | $14.40 | 2024 | Dynasplint |
| Merck Sharp & Dohme LLC | $12.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.